PDA Industry and Honor Award Winners
Class of 2024
Honorary Membership*
PDA's most prestigious award, conferring lifetime membership benefits to the recipient. The award is given in recognition of very long service, of a very significant nature, to PDA.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Frederick Carleton Award*
This award is designated for a past Board member whose services on the Board are determined by his/her peers as worthy of high recognition. It is presented as a tribute to lifetime contributor Fred Carleton.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Gordon Personeus Award*
This Award is intended to honor a PDA member for his or her long-term activities and/or volunteer contributions that are of noteworthy or special importance and have positively impacted PDA in several areas over time. It is presented in memory of the late Gordon Personeus, past PDA President and long-time volunteer.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Michael Korczynski Award*
This Award is presented to recognize contributions to PDA’s international activities. It is named for Michael S. Korczynski in recognition of the contributions he made toward the development of PDA’s international activities.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
James P. Agalloco Award
This award is presented annually to the PDA TRI faculty member who exemplifies outstanding performance in education. The selection is based on student and faculty evaluations. It is named for James P. Agalloco in honor of his work in developing the PDA education program.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Martin VanTrieste Pharmaceutical Science Award*
This award recognizes a volunteer’s outstanding contributions that have advanced the pharmaceutical sciences. It is presented in honor of past Board Member and long-time contributor Martin VanTrieste.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Edward Smith PDA Packaging Science Award*
This award was created to recognize outstanding contributions to Pharmaceutical Packaging Science. It is presented in honor of Edward Smith and his long-term contributions to pharmaceutical packaging science.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Distinguished Service Award*
Four to six awards are typically given in recognition of volunteers' special acts, contributions, or service over the last year that have contributed to the success and strength of PDA. Examples of the types of activities that are recognized include service as members and leaders of PDA Program Planning committees, Task Forces, Interest Groups, and Chapters.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Frederick Simon Award
This award is presented annually for the best paper published in the PDA Journal of Pharmaceutical Science and Technology (JPST). It is named in honor of the late Frederick D. Simon, a previous PDA Director of Scientific Affairs.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Letter Article of the Year Award
This reward recognizes an article written by a PDA member during the preceding year that proved popular with PDA’s audience. In addition, the Managing Editor and the Editorial Committee agrees that the article represents quality work deserving of special recognition.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Asia Pacific Appreciation Award
This award is given in recognition of special volunteer acts contributing to the success and strength of PDA in the Asia Pacific region.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Europe Appreciation Award
This award is given in recognition of special volunteer acts contributing to the success and strength of PDA in Europe.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Chapter of the Year Award
This award recognizes the outstanding PDA chapter of the year.
Outstanding Early Career Professional Award
This award is given in recognition of special volunteer acts contributing to the success and strength of PDA by an Early Career Professional
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Service Appreciation Award
This award is given in recognition of activities performed on behalf of PDA and is awarded at the end of service of specific volunteer leadership positions, including:
- The Board of Directors
- Advisory Board Chairs (intended to be given after stepping down as immediate past chair but can be given earlier when service is cut short)
- Interest Group Leaders
- Chapter Presidents
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA President’s Award
This Award recognizes a PDA staff member, typically excluding Senior Staff members, whose exemplary performance has contributed to PDA’s success during the previous year.
Jane Halpern, PhD
Dr. Halpern has over 25 years of experience in biologics development and has held positions in government as well as both small and large biotech companies. She worked at the FDA, Center for Biologics Evaluation and Research (CBER) as a researcher/reviewer for 10 years where she reviewed applications for both investigational and commercial products.
Dr. Halpern has held senior management positions at ID Biomedical Corporation, GSK Biologics, and Novavax Inc. At ID Biomedical Corporation, she led the global regulatory team that was responsible for obtaining FDA accelerated approval of a seasonal influenza vaccine and that supported the acquisition of ID Biomedical by GSK. She has experience with all stages of product development from newly discovered entities to lifecycle management of licensed products.
Dr. Halpern currently serves as a co-chair of the PDA Vaccine Interest Group and is a member of the Regulatory Affairs/Quality Assurance Advisory Board for PDA. She received her BS in Physiology from the University of California, Davis and her PhD in Pharmacology from the University of Rochester.
- Service Appreciation Award
Your rating for this document has already been submitted
Rate this document Average rating:Your rating for this document has already been submitted